Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Go back to Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates| (NASDAQ: XLO) | Delayed: 8.90 -0.04 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.94 | 52 Week High | $ | |||
| Open | $9.00 | 52 Week Low | $ | |||
| Day High | $9.30 | P/E | N/A | |||
| Day Low | $8.90 | EPS | $ | |||
| Volume | 32,261 | |||||

